Cherry Creek Investment Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-4,285
Closed -$231K – 91
2022
Q3
$231K Buy
+4,285
New +$220K 0.19% 76
2022
Q1
– Sell
-2,640
Closed -$264K – 106
2021
Q4
$264K Buy
2,640
+35
+1% +$3.62K 0.16% 88
2021
Q3
$326K Hold
2,605
– – 0.22% 77
2021
Q2
$324K Buy
+2,605
New +$350K 0.21% 77

Other funds holding GH

Cherry Creek Investment Advisors's GH Position: Q4 2022 in Review

Cherry Creek Investment Advisors sold out of Guardant Health (GH) in Q4 2022, closing a stake of 4,285 shares — an estimated $231K sold.

Cherry Creek Investment Advisors first reported a position in GH in Q2 2021 and held it in 4 quarters. The position peaked at $326K in Q3 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Cherry Creek Investment Advisors reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Cherry Creek Investment Advisors sold 4,285 Guardant Health shares in Q4 2022, an estimated $231K.
  • Cherry Creek Investment Advisors first reported a position in Guardant Health in Q2 2021 and held it in 4 quarters.
  • Cherry Creek Investment Advisors's Guardant Health position peaked at $326K in Q3 2021.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Cherry Creek Investment Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.